Accordingly, a higher TIM-3 expression on the luminal carcinoma subtypes (luminal A and luminal B) has been associated with a worse prognosis, whereas in basal-like triple-negative breast cancer, increased TIM-3 levels were associated with a more favorable prognosis [16]. The gene discussed is HAVCR2; the disease is triple-negative breast carcinoma.